Security key
29415J205
enVVeno Medical Corp - Common Stock, par value $0.00001 per share (NVNO)
CUSIP: 29415J205
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Common Stock, par value $0.00001 per share
- Total 13F shares
- 100,508
- Total 13F value
- $1,018,276
- Share change
- +91,960
- SEC-reported price per share
- $10.13
- Number of holders
- 17
- Value change
- +$931,685
- Number of buys
- 14
- Shares outstanding
- 656,455
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
17
Top holders
10
NVNO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
enVVeno Medical Corp SEC filings
enVVeno Medical Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29415J205
Recent filing periods:
Ownership snapshot
Top reported holders of NVNO - enVVeno Medical Corp - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PERCEPTIVE ADVISORS LLC
Disclosed value leader
Thomas A. Satterfield Jr.
Comparable rows
15/15
Latest evidence
20 Feb 2026
13F
13D/G
Lead comparable stake: 10%
13D/G row: PERCEPTIVE ADVISORS LLC
Showing 1-6 of 15 holder rows.
Quick read
PERCEPTIVE ADVISORS LLC leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PERCEPTIVE ADVISORS LLC's linked filing trail.
Comparable ownership
Top 5
PERCEPTIVE ADVISORS LLC
10%
Thomas A. Satterfield Jr.
9%
KINGDON CAPITAL MANAGEMENT, L.L.C.
5.5%
Braeden Lichti
5%
NORTHSTRIVE FUND II LP
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
13D/G
Company
|
10%
from 13D/G
|
$564,298
1,759,035 shares
|
— | 31 Dec 2025 |
| Thomas A. Satterfield Jr. |
13D/G
|
9%
|
$1,348,650
1,822,500 shares
|
$0 | 14 Nov 2025 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
13D/G
Company
|
5.5%
from 13D/G
|
$406,083
1,265,845 shares
|
— | 31 Dec 2025 |
| Braeden Lichti |
13D/G
|
5%
|
$331,842
33,151 shares
|
$0 | 20 Feb 2026 |
| NORTHSTRIVE FUND II LP |
13D/G
Braeden Lichti
|
5%
|
$331,842
33,151 shares
|
$0 | 20 Feb 2026 |
| Nantahala Capital Management, LLC |
13D/G
|
3.5%
|
$624,180
688,940 shares
|
-$540,807 | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
17
Shares
100,508
Rows available
17
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
17
Q1 2026 holders
17
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend